Northwire Canada EditionSunday, July 19, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
Financings

PyroGenesis Announces Closing of Third Tranche of the Non-Brokered Private Placement for $904,083

PYR · Price

Executive Summary

  • PyroGenesis Inc. closed the final tranche of its second‑unit group private placement, issuing a total of 14,185,969 units for gross proceeds of $5,226,083.
  • The financing consisted of two unit groups: the first at $0.63 per unit (5,555,556 units sold) and the second at $0.20 per unit (8,630,414 units sold).
  • Proceeds will be used for working capital and general corporate purposes; the placement is conditionally approved by the TSX pending final approval and customary closing conditions.

Key Details

  • Total Units Issued: 14,185,969 units (combined first and second unit groups).
  • Gross Proceeds: $5,226,083.
  • First Unit Group:
  • Price per unit: $0.63.
  • Composition: 1 common share + 1 common share purchase warrant (exercise price $0.28, exercisable for 48 months).
  • Units sold: 5,555,556 units → $3,500,000 gross proceeds.
  • Second Unit Group:
  • Price per unit: $0.20.
  • Composition: 1 common share + 1 common share purchase warrant (exercise price $0.40, exercisable for 24 months).
  • Units sold: 8,630,414 units → $1,726,083 gross proceeds.
  • Tranche Breakdown:
  • Second tranche of the second unit group: 4,520,414 units at $0.20 per unit → $904,083 gross proceeds.
  • First tranche of the second unit group (previously announced): 4,110,000 units at $0.20 per unit → $822,000 gross proceeds.
  • Use of Proceeds: Working capital and general corporate purposes.
  • Statutory Hold Period: Common shares and underlying warrants subject to a four‑month‑plus‑one‑day hold period from closing date.
  • Regulatory Status: Conditionally approved by the Toronto Stock Exchange; final approval and customary closing conditions remain pending.

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from PYROGENESIS INC.